# OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

> **NCT02872701** · PHASE2 · COMPLETED · sponsor: **On Target Laboratories, LLC** · enrollment: 100 (actual)

## Conditions studied

- Lung Neoplasms
- Lung Cancer

## Interventions

- **DRUG:** OTL38 for Injection
- **DEVICE:** Near infrared camera imaging system
- **PROCEDURE:** Endoscopic or Thoracic Surgery

## Key facts

- **NCT ID:** NCT02872701
- **Lead sponsor:** On Target Laboratories, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-04
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-11-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02872701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02872701, "OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02872701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*